Glycopyrrolate Injection is an anticholinergic indicated: in anesthesia (adult and pediatric patients) for reduction of salivary, tracheobronchial, and pharyngeal secretions, reduction of volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anesthesia and intubation. intraoperatively to counteract surgically or drug-induced or vagal reflex-associated arrhythmias.
From the U.S. FDA-approved label for Glycopyrrolate. Full label: DailyMed.
Glycopyrrolate Injection is an anticholinergic indicated: in anesthesia (adult and pediatric patients) for reduction of salivary, tracheobronchial, and pharyngeal secretions, reduction of volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anesthesia and intubation. intraoperatively to counteract surgically or drug-induced or vagal reflex-associated arrhythmias. for protection against peripheral muscarinic effects of cholinergic agents. in peptic ulcer (adults) To reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer when rapid anticholinergic effect is desired or oral medication is not tolerated.
From the U.S. FDA-approved label for Glycopyrrolate. Full label: DailyMed.
Glycopyrrolate injection may be administered intramuscularly (IM), or intravenously (IV) without dilution, in the following indications.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Glycopyrrolate injection is contraindicated in: patients with known hypersensitivity to glycopyrrolate injection or any of its inactive ingredients.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Precipitation of Acute Glaucoma: May cause mydriasis and increase intraocular pressure in patients with glaucoma. Advise patients with glaucoma to promptly seek medical care if they experience symptoms of acute angle closure glaucoma. Drowsiness or Blurred Vision: May cause drowsiness or blurred vision. Advise patients not to drive or perform hazardous work until resolved. Heat Prostration: Advise patients to avoid exertion and high environmental temperatures after receiving glycopyrrolate injection. Intestinal Obstruction: Diarrhea may be an early symptom of incomplete intestinal obstruction.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Adverse reactions to anticholinergics include xerostomia (dry mouth); urinary hesitancy and retention;
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
23 products from 18 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Glyco 4mg Injection | Glycopyrrolate (4mg) | National Healthcare Pvt. Ltd. | |
| Pyrolate 0.2mg Injection | Glycopyrrolate (0.2mg) | Neon Laboratories Ltd | |
| Airz Capsule | Glycopyrrolate (50mcg) | Glenmark Pharmaceuticals Ltd | packet of 30 capsules |
| Corolate 0.2mg Injection | Glycopyrrolate (0.2mg/1ml) | Miracalus Pharma Pvt Ltd | vial of 1 ml Injection |
| Gcolate 1mg Tablet | Glycopyrrolate (1mg) | Icon Life Sciences | strip of 10 tablets |
| Gcolate 2mg Tablet | Glycopyrrolate (2mg) | Icon Life Sciences | strip of 10 tablets |
| Glyco P 0.2mg Injection | Glycopyrrolate (0.2mg) | Khandelwal Laboratories Pvt Ltd | vial of 1 ml Injection |
| Glycoflo Neb 25mcg/2ml Transpules | Glycopyrrolate (25mcg/2ml) | Lupin Ltd | packet of 5 transpules |
| Glycohale Respules 1ml Each | Glycopyrrolate (25mcg) | Cipla Ltd | packet of 7 respules |
| Glycolate 0.2mg Injection | Glycopyrrolate (0.2mg) | Harson Laboratories | vial of 1 ml Injection |
| Glycolate 1 Tablet | Glycopyrrolate (1mg) | Intas Pharmaceuticals Ltd | strip of 10 tablets |
| Glycolate 2 Tablet | Glycopyrrolate (2mg) | Intas Pharmaceuticals Ltd | strip of 10 tablets |
| Glycover 0.2mg Injection | Glycopyrrolate (0.2mg) | Verve Healthcare Ltd | vial of 1 ml Injection |
| Glynium 25mcg Respules | Glycopyrrolate (25mcg) | Zydus Cadila | packet of 5 respules |
| Glynium Respicap | Glycopyrrolate (50mcg) | German Remedies | packet of 30 respicaps |
| Gpyrolon 0.2mg Injection | Glycopyrrolate (0.2mg) | Celon Laboratories Ltd | vial of 1 ml Injection |
| Licolate 0.2mg Injection | Glycopyrrolate (0.2mg) | Samarth Life Sciences Pvt Ltd | vial of 1 ml Injection |
| Lycolate 0.2mg Injection | Glycopyrrolate (0.2mg/1ml) | Biomiicron Pharmaceuticals | vial of 1 ml Injection |
| Nebzmart-G 25mcg Smartules 2ml | Glycopyrrolate (25mcg) | Glenmark Pharmaceuticals Ltd | packet of 5 respules |
| Pyrolate Injection | Glycopyrrolate (0.2mg) | Neon Laboratories Ltd | vial of 1 ml Injection |
| Pyrolin 0.2mg Injection | Glycopyrrolate (0.2mg) | Celon Laboratories Ltd | vial of 1 Injection |
| Pyrotroy 0.2mg Injection | Glycopyrrolate (0.2mg) | Troikaa Pharmaceuticals Ltd | vial of 1 ml Injection |
| Varcolate Injection | Glycopyrrolate (0.2mg) | Varenyam Healthcare Pvt Ltd | ampoule of 1 ml Injection |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Conditions Store at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
